tirzepatide biologic Zepbound From Eli Lilly and Company RCSB PDB - 7FIM: Cryo-EM
Description
In April 2025, the Trump Administration announced that Medicare and Medicaid would not cover anti-obesity drugs in 2026, reversing a prior expansion effort
Note that constipation can further delay gastric emptying and worsen nausea
It works as a dual GIP and GLP-1 receptor agonist , regulating appetite, slowing gastric emptying, and promoting fat loss
Brandon Richland, MD Tirzepatide is a relatively new addition to the lineup of medications prescribed for managing type 2 diabetes
